Sanai Health Industry Group Company Limited provided earnings guidance for the year ended 31 December 2022. For the year, the Group is expected to record (i) a revenue of approximately RMB 175.92 million for the year ended 31 December 2022 (the "Period''), representing an increase of approximately 160.2% as compared with the year ended 31 December 2021; and (ii) a profit attributable to owners of the Company of approximately RMB 29.22 million for the Period, representing an increase of approximately 223.6% as compared with the year ended 31 December 2021.